Introduction
Cancer is one of the top causes of death in the world, on the same level as strokes, respiratory diseases, and ischemic heart diseases. In 202, over 8 million people died of cancer (WHO). While there is no cure in the later stages of the disease, chemotherapy is one of the few reliable ways of treating cancer in an early stage. That procedure, however, is highly invasive and causes irreversible damage to the body, effectively shortening a persons lifespan by five to ten years (Masters et al. 794). Desperate people across the world spend their money on frauds and charlatans who offer fake promises of salvation but fail to deliver. Still, there is a cure.
Two years ago, research conducted by a small company run by Majid discovered that one of his painkillers cured 75% of lab rats affected with liver cancer. The product, Herbal, is a remedy based on natural ingredients and medicines. The product has passed initial trials on animals, achieving a 00% treatment success rate after being refined to treat cancer. A second stage of trials is planned. Herbal needs investors willing to offer support for t
he project and give a chance to millions of people around the world.
Approximately 3 million AED will be required to test and refine the product, pass through all the necessary regulatory procedures, and prepare a marketing campaign. Estimated benefits from this product are considerable, both in terms of money and in lives saved. The purpose of this business plan is to present the prospective cure to all and any potential investors who would be interested in becoming the first to promote a life-changing and profitable medical product that has no substitutes anywhere in the world.
Business Description
General Description
As the name of the company suggests, Herbal produces medicines based on natural ingredients and herbs. It has the facilities to test and manufacture its products, and both processes are certified according to the relevant UAE laws and regulations for medical businesses. It is a relatively small enterprise that evolved from a family business. Its current roster, including the board of directors, the laboratory team, and the employees in the production line total 00 people.
Industry Background